|The NT-ProBNP n/a (Catalog #MBS2090589) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Monoclonal Antibody to N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) reacts with Human, Mouse, Rat, Wild Boar, Porcine and may cross-react with other species as described in the data sheet. MyBioSource\'s N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP).
Western Blot: 0.5-5ug/mL
Immunocytochemistry: 5-30ug/mL. Researchers should empirically determine the suitability of the NT-ProBNP n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Monoclonal Antibody to N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP) with the following immunoassay(s):
Western Blot (WB) ((Western Blot; Sample: Rat Heart; Primary Ab: 1ug/ml Mouse Anti-Rabbit NT-ProBNP Antibody Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody ))
Western Blot (WB) ((Figure. Western Blot; Sample: Lane1: Human Serum; Lane2: Rat Heart Tissue.))
Buffer Formulation: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol. Buffer Formulation: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing NT-ProBNP are readily searchable from our website. Different antibodies against the same target such as NT-ProBNP may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.